For some reason I found this news. Interesting21 Sep 2021 09:01
AstraZeneca is planning on establishing a next-generation active pharmaceutical ingredient (API) manufacturing facility for small molecules near Dublin, Ireland to ensure the Company's global supply network is fit for future growth.